Autoimmune response following influenza vaccination in patients with autoimmune inflammatory rheumatic disease.

Abstract:

:Vaccines have undoubtedly brought overwhelming benefits to mankind and are considered safe and effective. Nevertheless, they can occasionally stimulate autoantibody production or even a recently defined syndrome known as autoimmune/inflammatory syndrome induced by adjuvants (ASIA). There is scarce data regarding autoimmune response after seasonal/influenza A (H1N1) vaccine in patients with autoimmune inflammatory rheumatic disease (AIRD). The objective of our study was therefore to determine autoimmune response in a large group of AIRD patients vaccinated against seasonal and/or H1N1 influenza. We conducted a prospective cohort study with a 6-month follow-up. Two-hundred and eighteen patients with AIRD (50 vaccinated against seasonal influenza, six against H1N1, 104 against both, 58 non-vaccinated controls) and 41 apparently healthy controls (nine vaccinated against seasonal influenza, three against H1N1, 18 against both, 11 non-vaccinated controls) were included. Blood samples were taken and screened for autoantibodies [antinuclear antibody (ANA), anti-extractable nuclear antigen (anti-ENA), anticardiolipin (aCL) IgG/IgM antibodies, anti-beta 2-glycoprotein I (anti-β2GPI)] at inclusion in the study, before each vaccination, 1 month after the last vaccination and 6 months after inclusion. For non-vaccinated participants (patients and healthy controls) blood samples were taken at the time of inclusion in the study and 6 months later. We report that after the administration of seasonal/H1N1 vaccine there were mostly transient changes in autoantibody production in AIRD patients and in healthy participants. However, a small subset of patients, especially ANA-positive patients, had a tendency towards anti-ENA development. Although no convincing differences between the seasonal and H1N1 vaccines were observed, our results imply that there might be a slight tendency of the H1N1 vaccine towards aCL induction. Although seasonal and H1N1 vaccines are safe and effective, they also have the potential to induce autoantibodies in selected AIRD patients and healthy adults. Follow-up of such individuals is proposed and further research is needed.

journal_name

Lupus

journal_title

Lupus

authors

Perdan-Pirkmajer K,Thallinger GG,Snoj N,Čučnik S,Žigon P,Kveder T,Logar D,Praprotnik S,Tomšič M,Sodin-Semrl S,Ambrožič A

doi

10.1177/0961203311429817

subject

Has Abstract

pub_date

2012-02-01 00:00:00

pages

175-83

issue

2

eissn

0961-2033

issn

1477-0962

pii

21/2/175

journal_volume

21

pub_type

杂志文章

相关文献

LUPUS文献大全
  • Monoclonal gammopathy in systemic lupus erythematosus.

    abstract::In order to ascertain the incidence of monoclonal gammopathy (MG) in systemic lupus erythematosus (SLE), 120 SLE patients were evaluated. Four patients (3.3%), two of whom were under 50 years of age, were found to have a monoclonal immunoglobulin in their serum. Our data agree with the previous literature in demonstra...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/096120339200100410

    authors: Porcel JM,Ordi J,Tolosa C,Selva A,Castro-Salomo A,Vilardell M

    更新日期:1992-08-01 00:00:00

  • Innate immunity and atherogenesis.

    abstract::Atherosclerosis is recognized as the pathological basis of cardiovascular disease (CVD) and recent advances in basic science have shown that it should be considered as a chronic inflammatory process. Both elements of the innate and the adaptive immunity appear to be actively involved in atherogenesis. In fact, the pot...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1191/0961203305lu2213oa

    authors: Rattazzi M,Faggin E,Bertipaglia B,Pauletto P

    更新日期:2005-01-01 00:00:00

  • Outcome criteria for lupus nephritis trials: a critical overview.

    abstract::Lupus nephritis is an important cause of morbidity and mortality in patients with systemic lupus erythematosus. Traditional outcome criteria such as doubling of serum creatinine, end-stage renal disease and death have been used in controlled therapeutic trials, but are limited by their low incidence and the extended p...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1191/096120398678920758

    authors: Boumpas DT,Balow JE

    更新日期:1998-01-01 00:00:00

  • Striking alteration of some populations of T/B cells in systemic lupus erythematosus: relationship to expression of CD62L or some chemokine receptors.

    abstract::Recent studies have revealed new populations of T/B cells, including central/effector memory, follicular T cells and CXCR3+ or CXCR4+ B cells. In the present study, changes in these populations of CD4+ T cells were examined on the basis of the expression of CD62L, CCR7 and CXCR5 in patients with systemic lupus erythem...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203307085246

    authors: Watanabe T,Suzuki J,Mitsuo A,Nakano S,Tamayama Y,Katagiri A,Amano H,Morimoto S,Tokano Y,Takasaki Y

    更新日期:2008-01-01 00:00:00

  • Is the development of drug-related lupus a contraindication for switching from one TNF alpha inhibitor to another?

    abstract::The use of TNF alpha (TNFalpha) inhibitors has made a strong impact on the management of rheumatoid and psoriatic arthritis, ankylosing spondylitis and Crohn disease. Side effects of these agents include the development of autoantibodies and a lupus-like syndrome (drug-related lupus, DRL). Here, a case of a patient wh...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203308093922

    authors: Kocharla L,Mongey AB

    更新日期:2009-02-01 00:00:00

  • Antimalarials as a risk factor for elevated muscle enzymes in systemic lupus erythematosus.

    abstract:OBJECTIVE:To investigate the relationship between antimalarials (AM) and elevated muscle enzymes in systemic lupus erythematosus (SLE). PATIENTSMETHODS:325 lupus patients with abnormal creatine phosphokinase (CPK) for at least two consecutive clinic visits were enrolled; 54 patients on statins/fibrates (n = 43) and/or...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203315617845

    authors: Tselios K,Gladman DD,Su J,Urowitz MB

    更新日期:2016-04-01 00:00:00

  • A clinical and serological comparison of familial and non-familial systemic lupus erythematosus in Ireland.

    abstract::Seventeen families, in which the diagnosis of SLE could be verified in two relatives, were included in the study. The diagnosis was made according to the revised 1982 ARA criteria. We compared the 34 cases of familial SLE in these 17 families with 34 non-familial SLE controls matched for age, sex, ethnicity and durati...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/096120339600500408

    authors: Gourley IS,Cunnane G,Bresnihan B,FitzGerald O,Bell AL

    更新日期:1996-08-01 00:00:00

  • Differences by race, sex and age in the clinical and immunologic features of recently diagnosed systemic lupus erythematosus patients in the southeastern United States.

    abstract::We examined the prevalence of clinical and immunologic features of systemic lupus erythematosus (SLE) by race, sex and age in a population-based study of 265 SLE patients. Patients fulfilled the American College of Rheumatology classification criteria. The median time between diagnosis and study enrollment was 13 mont...

    journal_title:Lupus

    pub_type: 杂志文章,多中心研究

    doi:10.1191/0961203302lu161oa

    authors: Cooper GS,Parks CG,Treadwell EL,St Clair EW,Gilkeson GS,Cohen PL,Roubey RA,Dooley MA

    更新日期:2002-01-01 00:00:00

  • Twenty-year follow-up: an unusual case of nephropathy of antiphospholipid syndrome.

    abstract::Nephropathy of antiphospholipid antibody syndrome (NAPS) is an increasingly well-recognized aspect of antiphospholipid syndrome. The most characteristic histopathology is that of thrombotic microangiopathy, and thrombosis occurring in the renal vasculature is thought to be the initiating event. Other less common patho...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203308098629

    authors: Lin YQ,Lakshminarayanan S,Yamase H,Palmisano J,Parke A

    更新日期:2009-05-01 00:00:00

  • Facial telangiectasia: an unusual manifestation of neonatal lupus erythematosus.

    abstract::Neonatal lupus erythematosus (NLE) is an uncommon condition usually associated with maternal anti-Ro autoantibodies. The cutaneous lesions of NLE are usually transient, disappearing about six months after birth, but telangiectasia is a rare complication of NLE which persists. Telangiectasias are small focal red macule...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203311430701

    authors: Guinovart RM,Vicente A,Rovira C,Suñol M,González-Enseñat MA

    更新日期:2012-04-01 00:00:00

  • Cutaneous lesions of the digits in systemic lupus erythematosus: 50 cases.

    abstract::The objective of this study was to observe the clinical and pathologic features of digital lesions in a cohort of 50 patients with systemic lupus erythematosus (SLE). Biopsy and pictures of digital lesions were performed in 50 consecutive patients with SLE and digital lesions. A clinical diagnosis of vasculitis was pr...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203306075792

    authors: Bouaziz JD,Barete S,Le Pelletier F,Amoura Z,Piette JC,Francès C

    更新日期:2007-01-01 00:00:00

  • Ferritin in the antiphospholipid syndrome and its catastrophic variant (cAPS).

    abstract:BACKGROUND:Ferritin is an iron storage protein considered also as an acute phase reactant with high levels in various inflammatory conditions. Recently, a plausible role for ferritin in the pathogenesis of immune-mediated and especially autoimmune diseases has been suggested. However, the link between ferritin and the ...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203313504633

    authors: Agmon-Levin N,Rosário C,Katz BS,Zandman-Goddard G,Meroni P,Cervera R,Stojanovich L,Blank M,Pierangeli S,Praprotnik S,Meis Ed,Seguro LP,Ruffatti A,Pengo V,Tincani A,Doria A,Shoenfeld Y

    更新日期:2013-11-01 00:00:00

  • Diagnostic ANCA algorithms in daily clinical practice: evidence, experience, and effectiveness.

    abstract::Detection of antineutrophil cytoplasmic antibodies (ANCA) for ANCA-associated vasculitides (AAV) is based on indirect immunofluorescence (IIF) on ethanol-fixed neutrophils and reactivity toward myeloperoxidase (MPO) and proteinase 3 (PR3). According to the international consensus for ANCA testing, presence of ANCA sho...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203316640921

    authors: Avery TY,Bons J,van Paassen P,Damoiseaux J

    更新日期:2016-07-01 00:00:00

  • Antiphospholipid syndrome in northwest Italy (APS Piedmont Cohort): demographic features, risk factors, clinical and laboratory profile.

    abstract::We report the experience from the Antiphospholipid Antibodies (aPL) Regional Consortium in northwest Italy, meant to support clinical research and foster collaboration among health professionals regarding the diagnosis and management of antiphospholipid syndrome (APS) patients. This cohort-study (APS Piedmont Cohort) ...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203312446974

    authors: Bertero MT,Bazzan M,Carignola R,Montaruli B,Silvestro E,Sciascia S,Vaccarino A,Baldovino S,Roccatello D,Antiphospholipid Piedmont Consortium.

    更新日期:2012-06-01 00:00:00

  • Acquired C1q deficiency caused by monoclonal paraproteinaemia.

    abstract::Acquired C1q deficiency secondary to anti C1q auto-antibodies may result in the hypocomplementaemic urticarial vasculitis syndrome and may also be seen in active systemic lupus erythematosus. Some patients with acquired C1 inhibitor deficiency are found to have an underlying malignancy, most commonly lymphoma. We repo...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/096120330000900113

    authors: Gordon MM,Lucie N,Porter D

    更新日期:2000-01-01 00:00:00

  • Reversible acute gastrointestinal syndrome associated with active systemic lupus erythematosus in patients admitted to hospital.

    abstract::Patients with systemic lupus erythematosus (SLE) frequently have gastrointestinal (GI) symptoms. These are usually self-limiting and related to treatment side-effects or concurrent illness. However, abdominal pain may be due to bowel ischaemia which can lead to infarction and perforation. The likelihood of these serio...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/0961203303lu433oa

    authors: Lian TY,Edwards CJ,Chan SP,Chng HH

    更新日期:2003-01-01 00:00:00

  • Cumulative dose of hydroxychloroquine is associated with a decrease of resting heart rate in patients with systemic lupus erythematosus: a pilot study.

    abstract:INTRODUCTION:The use of hydroxychloroquine (HCQ) in patients with systemic lupus erythematosus (SLE) offers a wide range of benefits. However, there are evidence in favour of cardiotoxicity, including heart conduction disturbances and congestive heart failure. OBJECTIVE:To determine the effects of HCQ in the resting h...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203315580870

    authors: Cairoli E,Danese N,Teliz M,Bruzzone MJ,Ferreira J,Rebella M,Cayota A

    更新日期:2015-10-01 00:00:00

  • Pregnancy loss and antiphospholipid antibodies.

    abstract::With the use of low-dose heparin, fetal survival of aPL pregnancies is 70-80%, but prematurity and intrauterine growth restriction are common. It is likely, but not proven, that dysregulated placental coagulation and resultant vasculopathy are the cause of fetal loss. Details of dysregulated coagulation remain to be d...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/096120339800700219

    authors: Lockshin MD

    更新日期:1998-01-01 00:00:00

  • Complementemia and obstetric outcome in pregnancy with antiphospholipid syndrome.

    abstract:OBJECTIVE:To investigate the predictive value of serum C3 and C4 complement component levels in relation to pregnancy outcome in patients with antiphospholipid syndrome (APS). MATERIALS AND METHODS:A prospective study of 47 pregnancies associated with APS was performed. Pregnancy outcome was analyzed in terms of: feta...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203312444172

    authors: De Carolis S,Botta A,Santucci S,Salvi S,Moresi S,Di Pasquo E,Del Sordo G,Martino C

    更新日期:2012-06-01 00:00:00

  • Antiphospholipid antibody-mediated effects in an arterial model of thrombosis are dependent on Toll-like receptor 4.

    abstract::Patients with antiphospholipid syndrome (APS) produce antiphospholipid antibodies (aPL) and develop vascular thrombosis that may occur in large or small vessels in the arterial or venous beds. On the other hand, many individuals produce aPL and yet never develop thrombotic events. Toll-like receptor 4 (TLR4) appears t...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203315603146

    authors: Laplante P,Fuentes R,Salem D,Subang R,Gillis MA,Hachem A,Farhat N,Qureshi ST,Fletcher CA,Roubey RA,Merhi Y,Thorin É,Levine JS,Mackman N,Rauch J

    更新日期:2016-02-01 00:00:00

  • Chloroquine treatment influences proinflammatory cytokine levels in systemic lupus erythematosus patients.

    abstract::Systemic lupus erythematosus (SLE) is an autoimmune disease with a complex pathogenesis. Published data have revealed that serum levels of proinflammatory cytokines are increased in SLE patients. The aim of our study was to evaluate whether monotherapy with chloroquine phosphate affects IL-1beta, IL-6, IL-18 and TNF-a...

    journal_title:Lupus

    pub_type: 临床试验,杂志文章

    doi:10.1191/0961203306lu2299oa

    authors: Wozniacka A,Lesiak A,Narbutt J,McCauliffe DP,Sysa-Jedrzejowska A

    更新日期:2006-01-01 00:00:00

  • Tumour necrosis factor alpha in systemic lupus erythematosus and anti-DNA autoantibody production.

    abstract::Tumour necrosis factor (TNFalpha) is a cytokine with a wide range of diverse and at times paradoxical effects. These include immunoregulatory, lymphoid organogenesis and pro-inflammatory effects. In recent years, TNFalpha has become a focus of interest more for its inflammatory effects in a number of chronic autoimmun...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1191/0961203302lu306rr

    authors: Mageed RA,Isenberg DA

    更新日期:2002-01-01 00:00:00

  • Clinical management of Lupus patients during the COVID-19 pandemic.

    abstract::Severe acute respiratory syndrome coronavirus (SARS-CoV-2), the virus causing Coronavirus disease 2019 (COVID-19), has had a huge impact on health services with a high mortality associated with complications including pneumonia and acute respiratory distress syndrome. Historical evidence suggests that Lupus patients h...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/0961203320961848

    authors: Mason A,Rose E,Edwards CJ

    更新日期:2020-11-01 00:00:00

  • Systemic lupus erythematosus pregnancies: a case series from a tertiary, East Malaysian hospital.

    abstract::We performed a retrospective study of all systemic lupus erythematosus (SLE) pregnancies during a two-year period (2006-2007) to describe the clinical features, maternal and foetal outcomes in our centre. There were 17 pregnancies in 16 women with SLE. Our patients have a mean age of 28.31 years (SD 5.24) and a mean d...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203308096661

    authors: Teh CL,Wong JS,Ngeh NK,Loh WL

    更新日期:2009-03-01 00:00:00

  • Towards evidence-based treatment of thrombotic antiphospholipid syndrome.

    abstract::Thrombosis in the presence of persistently positive tests for antiphospholipid antibodies is termed thrombotic antiphospholipid syndrome (APS). At present, 'standard' secondary thromboprophylaxis in thrombotic APS is treatment with moderate intensity oral anticoagulants for life after a first venous thrombosis and wit...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/0961203309361483

    authors: Derksen RH,de Groot PG

    更新日期:2010-04-01 00:00:00

  • Effectiveness of pharmaceutical care for drug treatment adherence in women with lupus nephritis in Rio de Janeiro, Brazil: a randomized controlled trial.

    abstract:OBJECTIVE:Studies have been conducted to determine the causal factors and clinical consequences of non-adherence to treatment in systemic lupus erythematosus (SLE). However, no interventions have been performed to increase drug adherence. Our objective was to assess the effectiveness of pharmaceutical care (PC) for dru...

    journal_title:Lupus

    pub_type: 杂志文章,随机对照试验

    doi:10.1177/0961203319877237

    authors: Oliveira-Santos M,Verani JFS,Camacho LAB,de Andrade CAF,Klumb EM

    更新日期:2019-10-01 00:00:00

  • Management of antiphospholipid antibody positivity and elective orthopedic procedures.

    abstract::Current management of primary or secondary antiphospholipid antibody (aPL) syndromes with known embolic phenomena requiring anticoagulation is empiric in the setting of elective orthopedic procedures. Short-term withdrawal of warfarin with continuance of aspirin and glucocorticoid therapy was undertaken for sequential...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/096120339200100311

    authors: Schnitz WM,Lister KA,McCarty GA

    更新日期:1992-05-01 00:00:00

  • Intrarenal macrophage infiltration induced by T cells is associated with podocyte injury in lupus nephritis patients.

    abstract::Proteinuria is the hallmark of clinical manifestation of disease activity in lupus nephritis (LN) patients, which arises from direct or indirect podocyte injury. This study is to explore the relationship between intrarenal T cell infiltration and podocyte injury in lupus nephritis (LN), and to understand the potential...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203316646861

    authors: Ma R,Jiang W,Li Z,Sun Y,Wei Z

    更新日期:2016-12-01 00:00:00

  • Association between TYK2 polymorphisms and susceptibility to autoimmune rheumatic diseases: a meta-analysis.

    abstract:OBJECTIVE:This study aimed to explore whether TYK2 polymorphisms are associated with susceptibility to autoimmune rheumatic diseases. METHODS:We conducted a meta-analysis on the association between TYK2 polymorphisms and autoimmune rheumatic diseases. RESULTS:Twelve studies with a total of 16,335 patients and 30,065 ...

    journal_title:Lupus

    pub_type: 杂志文章,meta分析

    doi:10.1177/0961203316638933

    authors: Lee YH,Bae SC

    更新日期:2016-10-01 00:00:00

  • Chronic or recurrent headache in patients with systemic lupus erythematosus: a case control study.

    abstract::Controversy exists concerning the prevalence of headache in systemic lupus erythematosus (SLE) and its importance as a neuropsychiatric manifestation, especially when it occurs independently of disease activity and with the typical characteristics of primary chronic headache. Most reports to date have either studied b...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/096120399678847443

    authors: Fernández-Nebro A,Palacios-Muñoz R,Gordillo J,Abarca-Costalago M,De Haro-Liger M,Rodríguez-Andreu J,González-Santos P

    更新日期:1999-01-01 00:00:00